课题基金 / 基金详情

Development of immunotherapeutics against Aspergillus fumigatus

Development of immunotherapeutics against Aspergillus fumigatus
烟曲霉免疫疗法的开发
批准号：
379932
负责人：
Sheppard Donald C
金额：
$57.12万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-03-01 至 2023-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=379932&lang=en
关键词：
Aspergillus Galactomannan Glycans Vaccines

项目摘要

项目成果

Sheppard Donald C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aspergillus fumigatus is a mold that commonly causes infections in patients with weak immune systems and those with long-term lung disease. We have developed a vaccine that protects animals from lethal challenge with Aspergillus and propose to study how t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification and characterization of a novel polysaccharide virulence factor of Aspergillus fumigatus
Human Fungal Infections - Targeting host-pathogen interactions to develop novel antifungal therapies
Recombinant hydrolases as anti-biofilm therapies for Aspergillus infections
Molecular mechanisms of Invasive Aspergillosis
  • 批准号：
    304495
  • 项目类别：
    Operating Grants
  • 资助金额：
    $56.91万
  • 财政年份：
    2014
  • 负责人：
    Sheppard Donald C
  • 依托单位：
    McGill University
海外基金